Sublingual Misoprostol Versus Manual Vacuum Aspiration for Treatment of Incomplete Abortion in Nigeria: A Randomized Control Study
Not Applicable
Completed
- Conditions
- Pregnancy and Childbirth
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 212
Inclusion Criteria
All consenting women at the study centres with first-trimester incomplete abortion, confirmed by a trans-abdominal ultrasound scan of the uterus, were eligible for the study
Exclusion Criteria
Women with excessive vaginal bleeding, severe anaemia (Hb < 7.0g%), or suspected ectopic pregnancy were excluded from the study.
A history of allergy to prostaglandins,
Evidence of genital infection such as offensive vaginal discharge, uterine tenderness, and pyrexia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie misoprostol's efficacy in treating incomplete abortion in Nigerian populations?
How does sublingual misoprostol compare to manual vacuum aspiration in terms of safety and effectiveness for incomplete miscarriage management in Nigeria?
Are there specific biomarkers that can predict response to misoprostol treatment in cases of incomplete abortion in low-resource settings?
What are the potential adverse events associated with sublingual misoprostol use for incomplete abortion and how can they be managed in clinical practice?
What alternative or combination therapies exist for treating incomplete abortion in Nigeria, and how do they compare to misoprostol in terms of accessibility and outcomes?